Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease

Neurobiology of Aging

Volumn 19, Issue SUPPL. 1, 1998, Pages

  Cotman, C W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; APOPTOSIS; BRAIN; CELL DEATH; CONFERENCE PAPER; DECISION MAKING; DNA DAMAGE; NERVE CELL; NERVE CELL DEGENERATION; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOPTOSIS; CELLS, CULTURED; HUMANS; MEMBRANE PROTEINS; NERVE DEGENERATION; PRESENILIN-1; SIGNAL TRANSDUCTION;

EID: 0031958152     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00042-6     Document Type: Conference Paper

References (47)

1. Abate C., Luk D., Curran T. A. Ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly. Cell Growth Differ. 1:1990;455-462.
2. Anderson, A. J.; Su, J. H.; Cotman, C. W. Increase in immunoreactivity for the DNA repair enzyme Ref-1 in Alzheimer's disease brain (submitted).
3. Anderson A. J., Su J. H., Cotman C. W. DNA damage and apoptosis in Alzheimer's disease Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay . J. Neurosci. 16:1996;1710-1719.
4. Anderson A. J., Cummings B. J., Cotman C. W. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease Association with pathology . Exp. Neurol. 125:1994;286-295.
5. Beal M. F., Hyman B. T., Koroshetz W. Do deficits in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? TINS. 16:1993;178-184.
6. Boerrigter M. E., Wei J. Y., Vijg J. DNA repair and Alzheimer's disease. J. Gerontol. 47:1992;B177-B184.
7. Copani A., Bruno V., Battaglia G., Leanza G., Pellitteri R., Russo A., Stanzani S., Nicoletti F. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by β-amyloid peptide. Mol. Pharmacol. 47:1995;890-897.
8. Copani A., Koh J.-Y., Cotman C. W. β-Amyloid increases neuronal susceptibility to injury by glucose deprivation [see comments]. Neuroreport. 2:1991;763-765.
9. Cotman C. W., Cribbs D. H., Pike C. J., Ivins K. J. Cell Death in Alzheimer's Disease. Lockshin R. A., Tilly J. L., Zakeri Z. Physiological cell death. 1998;385-409 Wiley-Liss, Inc, New York, NY.
10. Cotman C. W., Cribbs D. H., Anderson A. J. The β-amyloid model of Alzheimer's disease. Wasco W, Tanzi R. E. Molecular Mechanisms of Dementia. 1996;73-90 Humana Press, Inc, Totowa, NJ.
11. Cotman C. W., Su J. H. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6:1996;493-506.
12. Cotman C. W., Anderson A. J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:1995;19-45.
13. Cribbs D. H., Chen L. S., Bende S. M., LaFerla F. M. Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain. Am. J. Pathol. 148:1996;1797-1806.
14. Deng G., Pike C. J., Cotman C. W. Alzheimer associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett. 397:1996;50-54.
15. Dornan W. A., Kang D. E., McCampbell A., Kang E. E. Bilateral injections of βA(25-35)+IBO into the hippocampus disrupts acquisition of spatial learning in the rat. Neuroreport. 5:1993;165-168.
16. Estus S., Zaks W. J., Freeman R. S., Gruda M., Bravo R., Johnson E. M. Jr. Altered gene expression in neurons during programmed cell death identification of c-jun as necessary for neuronal apoptosis . J. Cell. Biol. 127:(6 Pt 1):1994;1717-1727.
17. Finch C. E., Cohen D. M. Aging, metabolism, and Alzheimer disease Review and hypotheses . Exp. Neurol. 143:1997;82-102.
18. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of β-amyloid fragment 25-35. Neuroreport. 4:1993;523-526.
19. Goto I., Taniwaki T., Hosokawa S., Otsuka M., Ichiya Y., Ichimiya A. Positron emission tomographic (PET) studies in dementia. J. Neurol. Sci. 114:1996;1-6.
20. Gschwind M., Huber G. Apoptotic cell death induced by β-amyloid 1-42 peptide is cell type dependent. J. Neurochem. 65:1995;292-300.
21. Ham J., Babij C., Whitfield J., Pfarr C. M., Lallemand D., Yaniv M., Rubin L. L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron. 14:1995;927-939.
22. Hoyer S. Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type. Ann. NY Acad. Sci. 695:1993;77-80.
23. Koh J. Y., Yang L. L., Cotman C. W. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
24. Loo D. T., Copani A. G., Pike C. J., Whittemore E. R., Walencewicz A. J., Cotman C. W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
25. 2+ homeostasis and cell death . J. Neurosci. 15:1995;6239-6249.
26. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
27. Mazzarello P., Poloni M., Spadari S., Focher F. DNA repair mechanisms in neurological diseases facts and hypotheses . J. Neurol. Sci. 112:1992;4-14.
28. McGeer P. L., Kamo H., Harrop R., Li D. K., Tuokko H., McGeer E. G., Adam M. J., Ammann W., Beattie B. L., Calne D. B., et al. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. Can. Med. Assoc. J. 134:1986;597-607.
29. Migheli A., Cavalla P., Piva R., Giordana M. T., Schiffer D. bcl-2 protein expression in aged brain and neurodegenerative diseases. Neuroreport. 5:1994;1906-1908.
30. Murphy G. M. Jr, Forno L. S., Ellis W. G., Nochlin D., Levy-Lahad E., Poorkaj P., Bird T. D., Jiang Z., Cordell B. Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease. Am. J. Pathol. 149:1996;1839-1846.
31. O'Barr S., Schultz J., Rogers J. Expression of the protooncogene bcl-2 in Alzheimer's disease brain. Neurobiol. Aging. 17:1996;131-136.
32. Page K., Hollister R., Tanzi R. E., Hyman B. T. In situ hybridization analysis of presenilin 1 mRNA in Alzheimer disease and in lesioned rat brain. Proc. Natl. Acad. Sci. USA. 93:1996;14020-14024.
33. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. Neurosci. 16:1996;7533-7539.
34. Parshad R. P., Sanford K. K., Price F. M., Melnick L. K., Nee L. E., Schapiro M. B., Tarone R. E., Robbins J. H. Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture. Proc. Natl. Acad. Sci. USA. 93:1996;5146-5150.
35. Pike C. J., Ramezan-Arab N., Cotman C. W. Evidence against a primary role of free radicals in the mechanism of β-amyloid neurotoxicity in vitro. J. Neurochem. 69:1997;1601-1611.
36. Portera-Cailliau C., Hedreen J. C., Price D. L., Koliatsos V. E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15:(5 Pt 2):1995;3775-3787.
37. Satou T., Cummings B. J., Cotman C. W. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res. 697:1995;35-43.
38. Schubert D., Chevion M. The role of iron in β amyloid toxicity. Biochem. Biophys. Res. Commun. 216:1995;702-707.
39. Su J. H., Deng G., Cotman C. W. Bax protein expression is increased in Alzheimer's brain correlations with DNA damage, Bcl-2 expression, and brain pathology . J. Neuropathol. Exp. Neurol. 56:1997;86-93.
40. Su J. H., Satou T., Anderson A. J., Cotman C. W. Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease. Neuroreport. 7:1996;437-440.
41. Su J. H., Cummings B. J., Cotman C. W. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res. 739:1996;79-87.
42. Su J. H., Anderson A. J., Cummings B. J., Cotman C. W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport. 5:1994;2529-2533.
43. Uchihara T., el Hachimi H. K., Duyckaerts C., Foncin J. F., Fraser P. E., Levesque L., St. George-Hyslop P. H., Hauw J. J. Widespread immunoreactivity of presenilin in neurons of normal and Alzheimer's disease brains Double-labeling immunohistochemical study . Acta Neuropathol. 92:1996;325-330.
44. Watt J. A., Pike C. J., Walencewicz-Wasserman A. J., Cotman C. W. Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons. Brain Res. 661:1994;147-156.
45. Weber L. L., Leissering M. A., Yang A. J., Glabe C. G., Cribbs D. H., LaFerla F. M. Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques. Exp. Neurol. 143:1997;37-44.
46. Wolozin B., Iwasaki K., Vito P., Ganjei J. K., Lacana E., Sunderland T., Zhao B., Kusiak J. W., Wasco W., D'Adamio L. Participation of presenilin 2 in apoptosis Enhanced basal activity conferred by an Alzheimer mutation . Science. 274:1996;1710-1713.
47. Yankner B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.